Your browser doesn't support javascript.
loading
High rate of dyspareunia and probable vulvodynia in Ehlers-Danlos syndromes and hypermobility spectrum disorders: An online survey.
Glayzer, Jennifer E; McFarlin, Barbara L; Castori, Marco; Suarez, Marie L; Meinel, Monya C; Kobak, William H; Steffen, Alana D; Schlaeger, Judith M.
  • Glayzer JE; Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
  • McFarlin BL; Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
  • Castori M; Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
  • Suarez ML; Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
  • Meinel MC; Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
  • Kobak WH; Department of Obstetrics and Gynecology, College of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.
  • Steffen AD; Department of Population Health Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
  • Schlaeger JM; Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
Am J Med Genet C Semin Med Genet ; 187(4): 599-608, 2021 12.
Article en En | MEDLINE | ID: mdl-34747110
ABSTRACT
Vulvodynia is debilitating vulvar pain accompanied by dyspareunia (pain with sexual intercourse). Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) may represent a predisposing factor for vulvodynia given a high rate of dyspareunia in these conditions. We conducted an online survey of women with EDS or HSD to assess rates of dyspareunia and estimate rates of vulvodynia, report rates of comorbid conditions common to EDS or HSD and vulvodynia, and examine rates of conditions contributing to dyspareunia in women with EDS or HSD. Women with EDS or HSD (N = 1,146) recruited via social media were 38.2 ± 11.5 years old, primarily White (94.4%), and resided in the United States (78.5%). 63.7% of participants reported dyspareunia and 50% screened positive for vulvodynia. The rate of comorbid conditions common to EDS or HSD and vulvodynia were irritable bowel syndrome, 6.5%; fibromyalgia, 40.0%; temporomandibular joint dysfunction, 56.4%; migraine, 6.7%; interstitial cystitis, 1.7%; and mast cell activation syndrome, 10.2%. Participants reporting dyspareunia also reported ovarian cysts, fibroids, or abdominal or pelvic scars, 47.5%; endometriosis, 26.5%; and genital lacerations, 19.3%. Women with EDS or HSD may have a higher rate of vulvodynia (50.0%) than women in the U.S. population at large (8%) and should be assessed for dyspareunia and vulvodynia.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dispareunia / Síndrome de Ehlers-Danlos / Vulvodinia / Síndrome de Activación de Mastocitos / Inestabilidad de la Articulación Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dispareunia / Síndrome de Ehlers-Danlos / Vulvodinia / Síndrome de Activación de Mastocitos / Inestabilidad de la Articulación Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article